Australia Combined (Multiplex) Point-Of-Care-Testing Market to 2032
Overview
The Australia Combined (Multiplex) Point-Of-Care-Testing Market is expected to reach a 48.72 by 2032 and is projected to grow at a CAGR of 12.58% from 2025 to 2032.
Revenue, 2024 ()
24.39
Forecast, 2032 ()
48.72
CAGR, 2024 - 2032
12.58%
Report Coverage
Australia
Australia Combined (Multiplex) Point-Of-Care-Testing Market 2018-2032
Australia Combined (Multiplex) Point-Of-Care-Testing Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 24.39
- Projected Market Size (2032): 48.72
- CAGR (2025-2032): 12.58%
Key Findings of Australia Combined (Multiplex) Point-Of-Care-Testing Market
- The Australia Combined (Multiplex) Point-Of-Care-Testing Market was valued at 48.72 in 2024.
- The Australia Combined (Multiplex) Point-Of-Care-Testing Market is likely to grow at a CAGR of 12.58% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Less Invasive in Sample Type Segment accounted for the largest share of the market with a revenue of 23.13
- The fastest growing segment SARS-CoV-2 /Influenza A/B in Virus Type Segment grew Fastest with a CAGR of 13.42% during the forecast period from 2024 to 2032.
Australia Combined (Multiplex) Point-Of-Care-Testing Market Scope
Australia Combined (Multiplex) Point-Of-Care-Testing Market Segmentation & Scope
Sample Type
- Non-Invasive
- Less Invasive
Functionality
- Semi-Automated
- Fully Automated
Product Type
- Others
- Systems
- Assays
Modality
- Standalone
- Benchtop
Virus Type
- Others
- Human Rhinovirus (RV)
- Rhino Scynthial Virus (RSV)
- Influenza B
- Influenza A
- SARS-CoV-2
- SARS-CoV-2 /Influenza A/B
End User
- Others
- Clinics
- Laboratories
- Hospitals
Australia Combined (Multiplex) Point-Of-Care-Testing Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in |
| Market Value in 2024 | 24.39 |
| Market Value in 2032 | 48.72 |
| CAGR (2025-2032) | 12.58% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Sample Type,Functionality,Product Type,Modality,Virus Type,End User |
Regional Insights:
-
Leading Market (2024-2032): Australia, leading in terms of revenue 24.39 in 2024
- Key Country: Australia, leading in terms of revenue with value of 24.39 in 2024.
Segments and Scope
-
Australia Combined (Multiplex) Point-Of-Care-Testing Market to 2032, By Sample Type
- Less Invasive is the largest segment in Australia Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a revenue of 23.13 in the year 2024.
- Less Invasive is the Fastest growing segment in Australia Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a Growth rate of 12.60 % in forecast period 2025-2032.
-
Australia Combined (Multiplex) Point-Of-Care-Testing Market to 2032, By Functionality
- Fully Automated is the largest segment in Australia Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a revenue of 20.67 in the year 2024.
- Fully Automated is the Fastest growing segment in Australia Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a Growth rate of 12.69 % in forecast period 2025-2032.
-
Australia Combined (Multiplex) Point-Of-Care-Testing Market to 2032, By Product Type
- Assays is the largest segment in Australia Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a revenue of 15.02 in the year 2024.
- Assays is the Fastest growing segment in Australia Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a Growth rate of 12.74 % in forecast period 2025-2032.
-
Australia Combined (Multiplex) Point-Of-Care-Testing Market to 2032, By Modality
- Benchtop is the largest segment in Australia Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a revenue of 14.75 in the year 2024.
- Benchtop is the Fastest growing segment in Australia Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a Growth rate of 12.68 % in forecast period 2025-2032.
-
Australia Combined (Multiplex) Point-Of-Care-Testing Market to 2032, By Virus Type
- SARS-CoV-2 /Influenza A/B is the largest segment in Australia Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a revenue of 8.22 in the year 2024.
- SARS-CoV-2 /Influenza A/B is the Fastest growing segment in Australia Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a Growth rate of 13.42 % in forecast period 2025-2032.
-
Australia Combined (Multiplex) Point-Of-Care-Testing Market to 2032, By End User
- Hospitals is the largest segment in Australia Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a revenue of 10.41 in the year 2024.
- Hospitals is the Fastest growing segment in Australia Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a Growth rate of 13.05 % in forecast period 2025-2032.
Australia Combined (Multiplex) Point-Of-Care-Testing Market Company Share Analysis
Australia Combined (Multiplex) Point-Of-Care-Testing Market Geographical Sales Distribution, 2018-2032
Australia Combined (Multiplex) Point-Of-Care-Testing Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Australia Combined (Multiplex) Point-Of-Care-Testing Market is segmented based on Segmentation Sample Type,Functionality,Product Type,Modality,Virus Type,End User.
Australia Combined (Multiplex) Point-Of-Care-Testing Market was valued at USD 24.39(Revenue in ) in 2021.
Australia Combined (Multiplex) Point-Of-Care-Testing Market is projected to grow at a CAGR of 12.58% during the forecast period of 2024 to 2032.
The Less Invasive segment is expected to dominate the Australia Combined (Multiplex) Point-Of-Care-Testing Market, holding a largest market share of 23.13 in 2024
Coming Soon....
Australia Combined (Multiplex) Point-Of-Care-Testing Market Scope
Australia Combined (Multiplex) Point-Of-Care-Testing Market Segmentation & Scope
Sample Type
- Non-Invasive
- Less Invasive
Functionality
- Semi-Automated
- Fully Automated
Product Type
- Others
- Systems
- Assays
Modality
- Standalone
- Benchtop
Virus Type
- Others
- Human Rhinovirus (RV)
- Rhino Scynthial Virus (RSV)
- Influenza B
- Influenza A
- SARS-CoV-2
- SARS-CoV-2 /Influenza A/B
End User
- Others
- Clinics
- Laboratories
- Hospitals
Frequently Asked Questions
The Australia Combined (Multiplex) Point-Of-Care-Testing Market is segmented based on Segmentation Sample Type,Functionality,Product Type,Modality,Virus Type,End User.
Australia Combined (Multiplex) Point-Of-Care-Testing Market was valued at USD 24.39(Revenue in ) in 2021.
Australia Combined (Multiplex) Point-Of-Care-Testing Market is projected to grow at a CAGR of 12.58% during the forecast period of 2024 to 2032.
The estimated market value of the Australia Combined (Multiplex) Point-Of-Care-Testing Market for final year is USD 48.72 ().
Australia Combined (Multiplex) Point-Of-Care-Testing Market Company Profiling
Frequently Asked Questions
The Australia Combined (Multiplex) Point-Of-Care-Testing Market is segmented based on Segmentation Sample Type,Functionality,Product Type,Modality,Virus Type,End User.
Australia Combined (Multiplex) Point-Of-Care-Testing Market was valued at USD 24.39(Revenue in ) in 2021.
Australia Combined (Multiplex) Point-Of-Care-Testing Market is projected to grow at a CAGR of 12.58% during the forecast period of 2024 to 2032.
The estimated market value of the Australia Combined (Multiplex) Point-Of-Care-Testing Market for final year is USD 48.72 ().
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.